Aspen Insurance Turns down $3.2B Bid from Endurance Specialty Holdings; Herbalife Says Not Aware of Any Probe


Follow this company

Companies Mentioned

NYSE:AHL / NASDAQ:SPLK / PK:ONCS / NYSE:HLF
04/15/2014 [ACCESSWIRE]

Aspen Insurance Holdings Ltd. (NYSE: AHL) – For an in-depth report on Aspen Insurance Holdings Ltd.: www.BullTrends.com/stockquote/AHL

Shares of Aspen Insurance Holdings closed up 11.18% on about 4.1 million shares traded. The stock was one of the biggest gainers on the NYSE and hit a new high of $46.86 during intra-day trading. The company has rejected an unsolicited offer from Endurance Specialty Holdings for them to acquire the company at $47.50 a share.

Splunk, Inc. (NASDAQ: SPLK) - For an in-depth report on Splunk, Inc. follow: www.BullTrends.com/stockquote/SPLK

Shares of Splunk Inc. closed up nearly 5% with about 6 million shares traded. The stock was one of the biggest gainers on the NASDAQ despite no news released. The stock had plunged nearly 50% from its February peak and saw a slight bounce on Monday.

OncoSec Medical Incorporated (OTC: ONCS) - For an in-depth report on OncoSec Medical Incorporated follow: www.BullTrends.com/stockquote/ONCS

Shares of ONCS closed down nearly 13% on Monday making it one of the biggest decliners in the OTC marketplace. The stock traded nearly 5.6 million shares without any significant news released. Earlier this month the company announced that it will re-launch its Phase II cutaneous T-cell lymphoma (CTCL) trial under a protocol amendment.

Herbalife Ltd. (NYSE: HLF) – For an in-depth report on Herbalife Ltd. follow: www.BullTrends.com/stockquote/HLF

Herbalife bounced back on Monday closing the day up with gains of almost 5%. The company was reported this past Friday to be under investigation by the FBI. Herbalife announced on Monday that they had no awareness of this and have not received any notice By the Department of Justice or the FBI.

 

Disclosure: BullTrends.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.

COMMENTS

Leave a comment...
 * 

Your Name
 *